Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

They must know the requirements for a NASDAQ up-listing.

To progress further on the current drug Trials paths it will cost. Just RS to $2 - $4 will Not fill the revenue requirement or valuation. But we've seen some questionable SPAC deals and claimed "IP valuations".

Maybe a couple of the INDs will be/are completed providing bargaining positions for access to partnerships and/or access to sponsors like cancer foundations etc.

Ifenprodil for Cancer tumors/SCLC and Chronic cough Clinical Trials with a back up of Micro-dosed DMT for stroke.?. Certainly a stronger portfolio of possibilities then many already in the Nasdaq with much higher valuations...IMHFO...

...GLTA...

https://bullishbears.com/nasdaq-uplisting-explained/